These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5505655)

  • 1. Serum complement, kidney disease and infection in patients with systemic lupus erythematosus.
    Futrakul P; Campbell RA
    J Med Assoc Thai; 1970 May; 53(5):346-8. PubMed ID: 5505655
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nephropathy in the prognosis of systemic lupus erythematosus].
    Zanetti NL; Fernández AE; Spresi FN; Marini A; Juárez Peñalva H; Capdevila A
    Medicina (B Aires); 1982; 42(2):127-35. PubMed ID: 6983021
    [No Abstract]   [Full Text] [Related]  

  • 3. [Whole serum complement in kidney diseases and systemic lupus erythematosus].
    Stein G; Stelzner A; Tanner E
    Z Gesamte Inn Med; 1973 Aug; 28(16):469-76. PubMed ID: 4129087
    [No Abstract]   [Full Text] [Related]  

  • 4. Silent lupus nephritis among patients with discoid lupus erythematosus.
    Roujeau JC; Belghiti D; Hirbec G; Poli F; Sobel AT; Revuz J; Touraine R
    Acta Derm Venereol; 1984; 64(2):160-3. PubMed ID: 6203307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation between immune complexes, anti-DNA antibodies and complement in lupus nephropathy].
    Pastore A; Manno C; Losuriello V; Vox E; Schena FP
    Minerva Nefrol; 1981; 28(4):503-8. PubMed ID: 7339520
    [No Abstract]   [Full Text] [Related]  

  • 6. [Consumption hypocomplementemia. Significance in human pathology].
    Ayed K; Ben Maiz H; Makni S; Ben Redjeb S; Boujnah A
    Tunis Med; 1983; 61(2):89-91. PubMed ID: 6680958
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-immunological evaluation of the activity of total complement of the blood serum of patients with systemic lupus erythematosus].
    Zhuravlev GI; Rodshtein OA
    Ter Arkh; 1972 Nov; 44(11):29-33. PubMed ID: 4125143
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum complement in human kidney diseases].
    Lagrue G; Bariéty J; Halpern B; Milliez P
    Pathol Biol; 1967 Apr; 15(7):378-83. PubMed ID: 4864895
    [No Abstract]   [Full Text] [Related]  

  • 9. Pleural effusion in systemic lupus erythematosus.
    Reda MG; Baigelman W
    Acta Cytol; 1980; 24(6):553-7. PubMed ID: 6160709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunological evaluation of pleural effusions in systemic lupus erythematosus.
    Small P; Frank H; Kreisman H; Wolkove N
    Ann Allergy; 1982 Aug; 49(2):101-3. PubMed ID: 7103145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus band test in patients with systemic lupus erythematosus.
    Tsay GJ; Chao LS; Liu GY; Lin CS
    Taiwan Yi Xue Hui Za Zhi; 1983 Apr; 82(4):530-5. PubMed ID: 6579207
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum complement determinations in patients with quiescent systemic lupus erythematosus.
    Sullivan KE; Wisnieski JJ; Winkelstein JA; Louie J; Sachs E; Choi R; Veksler E; Goldman D; Petri M
    J Rheumatol; 1996 Dec; 23(12):2063-7. PubMed ID: 8970042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrosedimentation and serum complement as parameters of clinical activity in systemic lupus erythematosus.
    Rivero I; Moravenik M; Diumenjo MS; Vannucci J
    Rev Clin Esp; 1977 Dec; 147(5):495-8. PubMed ID: 605255
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
    Jin A
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
    [No Abstract]   [Full Text] [Related]  

  • 15. [The early components of complement in glomerular deposits].
    Berger J; Yaneva H
    Minerva Nefrol; 1973; 20(4):177-80. PubMed ID: 4789738
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV; Selivanova IA; Poroshina NS; Gagarina LN
    Vopr Revm; 1973; 13(2):51-2. PubMed ID: 4772875
    [No Abstract]   [Full Text] [Related]  

  • 17. Mortality patterns in Malaysian systemic lupus erythematosus patients.
    Yeap SS; Chow SK; Manivasagar M; Veerapen K; Wang F
    Med J Malaysia; 2001 Sep; 56(3):308-12. PubMed ID: 11732075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].
    Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A
    Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum complement in systemic lupus erythematosus (SLE).
    Asano S; Marumo K; Igaki Y; Toyoizumi E; Okubo M
    Arerugi; 1968 Jul; 17(7):597-609. PubMed ID: 5726584
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.